Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Louisiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Louisiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Louisiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jyothi Mallepalli (NPI 1184635344)

Field	Value
Entity Type	Individual
Organization	Jyothi Mallepalli
Address	3402 Magnolia Cove
City	Monroe
State	LA
ZIP	71203
Taxonomy	Rheumatology Physician
NPI Enumerated	August 11, 2006

Payer Source	Total Paid
Medicare	$3.2M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-focused rheumatology practice: lifetime Medicare revenue is reported at $3.2M while there is no Medicaid billing on file, indicating a single-payer footprint in the available data and limited participation in state Medicaid programs. Analysts should treat this profile as Medicare-dominant when assessing payer strategy and network value in Louisiana.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 54.7% of this provider’s total Medicare revenue, indicating that a small set of drug/infusion CPT/HCPCS codes drives more than half of billings. That concentration suggests business risk tied to utilization or reimbursement changes for those specific therapies.

The highest-revenue single code is J3262 (injection, tocilizumab, 1 mg) with $793.3K in Medicare revenue (25.0% of total Medicare revenue) and the provider ranks #16 of 618 nationally on this code, a placement described as notably above typical national volume. This implies the provider is a major national-level user of tocilizumab in Medicare, consistent with a clinic that administers or supervises significant biologic therapy.

J0717 (certolizumab pegol, 1 mg) and J1602 (golimumab, 1 mg) together account for a further large share of revenue ($489.6K and $455.4K respectively, 15.4% and 14.3% of Medicare revenue). Both codes are within typical national volume ranges (88th and 93rd percentiles described as unremarkable or typical), signaling steady high-volume prescribing/administration of a mix of biologic agents commonly used in rheumatology.

Several codes are flagged as statistical outliers or extreme outliers in national rank: 99214 (office E/M for established patient) appears as an extreme outlier (100th percentile) with $303.4K (9.5% of Medicare revenue), and chemotherapy administration code 96401 ranks as an extreme outlier (100th percentile) with $83.2K (2.6% of Medicare revenue). These placements suggest unusually high volumes of moderate-complexity office visits and parenteral drug administrations relative to peers, reinforcing a high-throughput clinic model focused on in-office treatments.

Multiple lab and imaging codes (for example 80053, 36415, 85025, 86140, 82306, 77080) appear with notable national percentile placements (many in the 90s) and collectively represent lower-dollar but consistent service volume, consistent with an ambulatory rheumatology practice that performs diagnostic monitoring and point-of-care testing to support biologic therapy management. These ancillary services complement the drug-administration revenue stream.

Tenure in the Medicare program is long: the NPI was enumerated on 2006-08-11 (~20 years ago), indicating established presence and likely long-standing referral relationships. That duration supports the volume findings and suggests the provider has sustained its service mix over time.

Competitive standing is mixed by code: for J3262 the provider is a national high-volume contributor (98th percentile, rank #16 of 618), indicating leadership for that drug; for several other high-revenue drugs (J0717, J1602) the provider is high-volume but within typical ranges (88th–93rd percentiles), suggesting it is a meaningful regional contributor but not uniquely dominant across all biologics. Overall, the practice should be viewed as a high-volume, Medicare-focused rheumatology infusion/administering center with concentrated revenue exposure to a few biologic agents.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

65 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3262	Injection, tocilizumab, 1 mg	158,650	$10	$793.3K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	122,400	$1	$489.6K
J1602	Injection, golimumab, 1 mg, for intravenous use	41,400	$10	$455.4K
J0897	Injection, denosumab, 1 mg	17,100	$20	$307.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	3,570	$90	$303.4K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	6,730	$30	$228.7K
J3111	Injection, romosozumab-aqqg, 1 mg	24,570	$10	$196.6K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	1,630	$50	$83.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	510	$90	$45.5K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	3,490	$10	$34.9K

Showing 1–10 of 65

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 65 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Louisiana Distribution

Jyothi Mallepalli — 16 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Louisiana

Full comparison — all codes billed, vs. state median

65 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J1602	5	10	26,920	$10	$526.5K
J0129	10	10	9,490	$30	$506.1K
J3262	1	10	55,770	$1	$329.7K
J0717	2	10	55,200	$1	$263K
J3111	4	10	16,800	$10	$161.1K
J0897	4	70	3,120	$20	$105.6K
96413	10	70	140	$90	$22.8K
99214	3	6,670	110	$80	$16.5K
96401	1	50	130	$50	$12.9K
99215	537	1,650	40	$110	$8.4K

Showing 1–10 of 65

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jyothi Mallepalli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
James Keane	AR	Procedural Dermatology Physician	$4.9M	$0
Harshivinderjit Bains	TX	Ophthalmology Physician	$4.1M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Shanda Jackson	LA	Family Nurse Practitioner	$4M	$0
Amar Patel	TX	Ophthalmology Physician	$3.8M	$0
Thomas Bochow	TX	Ophthalmology Physician	$3.6M	$0
James Russo	LA	Radiation Oncology Physician	$3.5M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K
Stephen Price	LA	Physician Assistant	$3.4M	$0

Nearby Providers

Other providers in the same ZIP code as Jyothi Mallepalli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Pecan Haven Addiction Recovery Center, LLC	LA	Substance Abuse Rehabilitation Facility	$0	$42.3M
Cognitive Development Center Behavioral Health Services	LA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$38.1M
Absolute Care,inc.	LA	Assisted Living Facility	$0	$16.8M
Inspirational Care LLC	LA	In Home Supportive Care Agency	$0	$11.5M
Melanie Massey Physical Therapy Inc	LA	Physical Therapist	$0	$11.4M
Unique Guidance Provider Services, Inc	LA	In Home Supportive Care Agency	$0	$8.3M
Ann's Helping Hands	LA	Personal Care Attendant	$0	$5.3M
Inspirational Care LLC	LA	In Home Supportive Care Agency	$0	$5.3M
Laboratory Corporation Of America Holdings	LA	Clinical Medical Laboratory	$1.2M	$3.4M
Luke Hunter	LA	Foot & Ankle Surgery Podiatrist	$126.4K	$387.7K

Jyothi Mallepalli — Billing Profile & Reimbursement Data

Sign up for Jyothi Mallepalli — Billing Profile & Reimbursement Data policy alerts

Jyothi Mallepalli — Billing Profile & Reimbursement Data

Sign up for Jyothi Mallepalli — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References